| mRNA |
BRD8899 |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
2e-08 |
| mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
2e-05 |
| mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-05 |
| mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
3e-05 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
3e-05 |
| mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
4e-05 |
| mRNA |
BRD-K19103580 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
8e-05 |
| mRNA |
Parthenolide |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0001 |
| mRNA |
A-804598 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
0.0003 |
| mRNA |
ML203 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0004 |